Evidence map›Paper›PMID 42609386›Full record

ArticleFrontiers in behavioral neuroscience2026

Development of a deep learning-based grid walking test for assessing post-stroke motor function in mice.

Monika Maciag, Vardan T Karamyan

Abstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Monika MaciagDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, United States.
Vardan T KaramyanDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, United States.

Funding

Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke TherapyR01NS106879 · NINDS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Thomas J Abbruscato, Vardan T. Karamyan · 2018 to 2026
$4.2M
NINDS NIH HHS R01 NS106879
6 · The paper itself

Abstract

Stroke is a leading cause of death and disability, affecting over 15 million people each year. Developing effective therapies depends on accurate, scalable methods to assess sensorimotor recovery in preclinical models. Standard motor tests like grid walking and ladder tests rely on manual scoring, limiting objectivity and throughput. To address this, we compared a commercially available automated ladder test with a newly developed deep learning-based grid walking test using DeepLabCut (DLC) in a photothrombotic stroke model in mice. Our results show that the automated ladder test system failed to detect significant unilateral deficits in stroke animals. It did not capture the expected increase in missteps in the affected forepaw after stroke, even though motor cortex infarcts were confirmed histologically, and the functional impairment was apparent with manual scoring in the grid walking test. In contrast, our DLC-based grid walking model provided fully automated quantification of this widely used test. It achieved millimeter-scale tracking accuracy and detected a ∼3-fold increase in foot faults in stroke-affected mice compared to controls, clearly differentiating between affected and unaffected forepaws for at least 2 weeks post-stroke. These findings expose the limitations of the commercial automated ladder test and demonstrate that the DLC-based pose-estimation-assisted misstep quantification in grid-walk test provides greater sensitivity for detecting motor deficit.

Indexed as

artificial intelligenceautomated ladder testautomated motor assessmentbehavioral testingfoot fault testmachine learningphotothrombotic stroke modelstroke recovery

Identifiers

PMID42609386
PMCPMC13478089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.